Cancer Drug Birinapant Cures Mice Of Hepatitis B

  • metta

    Posts: 39118

    Apr 23, 2015 7:26 PM GMT
    Cancer Drug Cures Mice Of Hepatitis B


    http://www.iflscience.com/health-and-medicine/cancer-drug-cures-mice-hepatitis-b
  • Posted by a hidden member.
    Log in to view his profile

    Apr 24, 2015 1:40 AM GMT
    There is also a vaccine for Hep B. It comes in 3 shots. I had it done and had no side effects whatsover.
  • Posted by a hidden member.
    Log in to view his profile

    Apr 24, 2015 4:14 PM GMT
    While this is great news, most patients infected with Hep B recover. Only 5% of those infected wind up with chronic hepatitis and risks of hepatocellular carcinoma or cirrhosis. This combined with the vaccine makes Hep B more of a concern for 3rd world, impoverished or marginalized groups, or vaccine non-converters.

    In case you're interested, we also now have a "cure" for Hep C now! Hep C is much for concerned given the fact there is no vaccine and the chronicity rates are much much higher than Hep B. Drug is called Sofosbuvir and its replacing interferon and ribavirin! Cures up to 90% of patients. Down side is the 12-week course of Sofosbuvir will run you $80-90K. Totally worth it though - as it will save your life.
  • venue35

    Posts: 4644

    Apr 25, 2015 10:07 AM GMT
    I can't believe the treatment would cost this much.
  • Posted by a hidden member.
    Log in to view his profile

    Apr 25, 2015 7:10 PM GMT
    [quote][cite]MuchMoreThanMuscle said[/cite]
    coloradojock16 said
    In case you're interested, we also now have a "cure" for Hep C now!


    ^ There has been a cure for Hepatitis since the 1990's. Interferon and ribavirin have been around for that long. Granted, the cure rate was lower (than the new drug you've mentioned) and treatment takes nearly a year to complete.



    Ya, I mentioned Rebetron (INF-a + ribavirin) in my post. The success rate was a dismal ~45% in most studies. The less that 50% success coupled with the fact that 75-85% of those infected develop chronic hepatitis (vs. 5-10% with HBV), lead me to say we now finally have a 'cure'. Now with Sovaldi, the success rate has reach up to 98% in many studies. The recommended treatment time is a 12 week course. This can be extended to longer 24 week courses in instances of cirrhosis